Valuation: China Isotope & Radiation Corporation

Market Cap 321.55Cr 377.45Cr 48Cr 43Cr 40Cr 36Cr 68Cr 4.56TCr 69Cr 477.82Cr 188.22Cr 2.39TCr 180.79Cr 176.92Cr 7.57TCr P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 333.44Cr 391.4Cr 50Cr 45Cr 41Cr 37Cr 70Cr 4.73TCr 71Cr 495.48Cr 195.18Cr 2.48TCr 187.48Cr 183.46Cr 7.85TCr EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.44%
Yield 2024
3.74%
Yield 2025 1.69%
22/10 China Isotope & Radiation to Issue New Shares in Subsidiary; Shares Fall 4% MT
22/10 China Isotope & Radiation Declares Interim Dividend MT
21/10 China Isotope & Radiation Corporation Approves Appointment of Li Penghui as Executive Director, Effective 21 October 2026 CI
21/10 China Isotope & Radiation Corporation Approves Interim Dividend for the Six Months Ended 30 June 2026, Payable Before 18 December 2026 CI
12/10 CIRC Unit's H. Pylori Breath Test Kit Wins China Drug Registration Approval MT
23/09 China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review MT
28/08 China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 CI
28/08 China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 18 December 2026 CI
28/08 China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026 CI
28/08 China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026 CI
06/07 China Isotope to Form JV With Associate MT
03/07 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
18/06 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
1 day-0.72%
1 week-4.84%
Current month-11.72%
1 month-17.14%
3 months-32.36%
6 months-37.83%
Current year-42.57%
1 week 11
Extreme 11
12.44
1 month 11
Extreme 11
14.43
Current year 11
Extreme 11
24.28
1 year 11
Extreme 11
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
26.5
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 54 28/08/2026
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 57 22/02/2017
Director/Board Member 54 28/06/2019
Director/Board Member 54 30/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%-4.84%-32.56%-3.17% 50Cr
+1.99%-2.07%-19.88%+5.92% 17TCr
+3.19%+4.72%-20.93%+15.58% 11TCr
+3.83%+1.19%+0.72%+32.86% 11TCr
+1.93%+19.13%-43.11%+8.64% 8.96TCr
-0.57%-0.86%+2.32%+79.33% 6.5TCr
-0.74%+2.09%+13.87%+80.59% 5.61TCr
+3.13%+3.44%+6.54%-22.51% 5.29TCr
+2.40%+3.58%-10.57%+32.73% 4.36TCr
+3.43%+4.93%-5.06%-10.63% 3.28TCr
Average +1.79%+3.64%-10.87%+21.93% 7.42TCr
Weighted average by Cap. +2.19%+3.78%-12.12%+22.74%

Financials

2024 2025
Net sales 757.48Cr 889.16Cr 113.46Cr 101.28Cr 93Cr 85Cr 159.25Cr 11TCr 161.7Cr 1.13TCr 443.39Cr 5.63TCr 425.89Cr 416.77Cr 18TCr 718.77Cr 843.72Cr 107.66Cr 96Cr 89Cr 81Cr 151.11Cr 10TCr 153.43Cr 1.07TCr 420.73Cr 5.34TCr 404.13Cr 395.47Cr 17TCr
Net income 41Cr 48Cr 6.09Cr 5.44Cr 5.02Cr 4.56Cr 8.55Cr 576.98Cr 8.68Cr 60Cr 24Cr 302.29Cr 23Cr 22Cr 957.63Cr 33Cr 38Cr 4.9Cr 4.38Cr 4.04Cr 3.67Cr 6.88Cr 464.57Cr 6.99Cr 49Cr 19Cr 243.4Cr 18Cr 18Cr 771.07Cr
Net Debt -11Cr -13Cr -1.63Cr -1.46Cr -1.34Cr -1.22Cr -2.29Cr -154.56Cr -2.33Cr -16Cr -6.38Cr -81Cr -6.12Cr -5.99Cr -256.53Cr 12Cr 14Cr 1.78Cr 1.59Cr 1.47Cr 1.33Cr 2.5Cr 168.62Cr 2.54Cr 18Cr 6.96Cr 88Cr 6.68Cr 6.54Cr 279.86Cr
Projected Income Statement - Annual - China Isotope & Radiation Corporation
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,655
Date Price Change Volume
23/26/23 HK$11.62 -0.55% 10,600
22/26/22 HK$11.80 -2.96% 3,65,000
21/26/21 HK$12.16 +1.50% 50,400
20/26/20 HK$11.98 -1.72% 1,26,600
16/26/16 HK$12.19 +1.84% 1,14,200

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - China Isotope & Radiation Corporation
  1. Stock Market
  2. Stocks
  3. 1763 Stock